Letroplex

AXIOLABS LETROPLEX

Letroplex, manufactured by Axiolabs, is a medication containing Letrozole 2.5 mg. It falls under the class of aromatase inhibitors, specifically designed to treat hormone receptor-positive breast cancer.

DRUG COMPOSITION

Each Letroplex tablet contains Letrozole 2.5 mg.

PHARMACEUTICAL FORM

Letroplex is formulated as oral tablets, facilitating accurate and convenient dosing.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antineoplastic agents, ATC code: L02BG04 - Letrozole.

PHARMACOLOGICAL PROPERTIES

Letroplex exerts its pharmacological effects by inhibiting the aromatase enzyme. This inhibition prevents the conversion of androgens into estrogens, reducing estrogen levels. Lower estrogen levels are particularly beneficial in the treatment of hormone-sensitive breast cancer.

PROFILE

• Chemical name: 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile
• Chemical formula: C17H11N5
• Percentage of anabolic activity: Not a steroid
• Percentage of androgenic activity: Not a steroid
• Active half life: 2 days
• Recommended dosage: 0.5-2.5 mg/day
• Acne: no
• Bloating (water retention): no
• HBR: no
• Hepatic toxicity: no
• Aromatization: Inhibits aromatase, preventing estrogen conversion

THERAPEUTICAL INDICATIONS

Letroplex is indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. It is also prescribed for the extended adjuvant treatment of early breast cancer in postmenopausal women who have received five years of adjuvant tamoxifen therapy.

DOSES AND METHOD OF ADMINISTRATION

The standard dosage of Letroplex is typically one 2.5 mg tablet taken orally once a day, with or without food.

CYCLE/STACKING

Solo cycle:

• Letroplex is commonly used as a standalone medication for breast cancer treatment. A typical dosage might be 2.5 mg once a day.

Cutting cycle:

• Letroplex 2.5 mg per day + Exeplex (Exemestane) 25 mg per day for a 12-week cutting cycle.

Bulking cycle:

• Letroplex is not typically used in bulking cycles, as its primary application is in breast cancer treatment.

POST CYCLE THERAPY

Letroplex is not commonly used in post-cycle therapy for bodybuilding, as its primary role is specific to breast cancer treatment.

SIDE EFFECTS

Common side effects may include hot flashes, joint pain, and fatigue. Serious side effects may include bone density reduction and an increased risk of fractures.

CONTRAINDICATIONS

Letroplex is contraindicated in pregnant or breastfeeding women, individuals with severe hepatic impairment, and those with known hypersensitivity to Letrozole.

OVERDOSE

In case of overdose, seek medical attention. Symptomatic and supportive measures may be recommended.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Letroplex may cause a reduction in bone mineral density, and regular monitoring is advisable.

INTERACTIONS WITH OTHER DRUGS

Letroplex may interact with medications that induce or inhibit cytochrome P450 enzymes. Inform healthcare providers about all medications being taken.

PRESENTATION, PACKAGING

2.5 mg per tablet, 50 tablets in sachet.

STORAGE

Store Letroplex in a cool, dry place, away from direct sunlight.

LEGAL STATUS

Letroplex is often available only by prescription and is subject to legal regulations. Its use for non-medical purposes may be subject to legal restrictions depending on the country or region.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Axiolabs
Europe

EXTERNAL LINKS

• Letrozole Wiki, wikipedia.org
• Letrozole Uses, Side Effects & Warnings, drugs.com
• Letrozole Oral: Uses, Side Effects, Interactions, Pictures, medlineplus.gov.